AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from the ...

IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. Use this policy to establish a set of best practices for the issuance, management, ...